NPLEX I flashcards
NPLEX I · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Rate-limiting enzyme of glycolysis
- Phosphofructokinase-1 catalyzes the committed step of glycolysis and is inhibited by ATP and citrate while activated by AMP and fructose-2,6-bisphosphate.
- Chemiosmotic ATP yield
- Each NADH oxidized in the electron transport chain yields roughly 2.5 ATP, and each FADH2 yields roughly 1.5 ATP via ATP synthase.
- Km and enzyme affinity
- Km is the substrate concentration giving half-maximal velocity. A low Km indicates high affinity; competitive inhibitors raise apparent Km without altering Vmax.
- Hardy-Weinberg carrier frequency
- For an autosomal recessive condition in equilibrium, carrier frequency equals 2pq, where p and q are the allele frequencies and q-squared is the disease incidence.
- Resting membrane potential basis
- Resting potential near -70 mV in neurons depends chiefly on potassium permeability, maintained by the Na+/K+ ATPase moving three sodium out per two potassium in.
- Starling force equation
- Net capillary filtration equals capillary hydrostatic plus interstitial oncotic pressure minus interstitial hydrostatic plus capillary oncotic pressure; hypoalbuminemia promotes edema.
- Innate versus adaptive immunity
- Innate immunity acts within minutes through neutrophils, macrophages, complement, and NK cells; adaptive immunity uses clonal lymphocyte selection and generates immunologic memory.
- Respiratory versus metabolic compensation
- Metabolic acid-base disorders are compensated by rapid ventilatory change, whereas respiratory disorders require renal compensation that develops over days.
- Cardiac troponin kinetics
- Troponin rises about three to six hours after myocardial injury, peaks near twenty-four hours, and may remain elevated for one to two weeks.
- Diabetes diagnostic thresholds
- Diabetes is diagnosed by fasting glucose at or above 126 mg/dL, two-hour OGTT at or above 200 mg/dL, or HbA1c at or above 6.5 percent.
- Primary hypothyroidism laboratory pattern
- Primary hypothyroidism shows an elevated TSH with a low free T4, whereas primary hyperthyroidism shows a suppressed TSH with elevated free T4 and T3.
- Anemia by mean corpuscular volume
- Microcytic anemia suggests iron deficiency, thalassemia, or chronic disease; normocytic suggests blood loss, renal disease, or hemolysis; macrocytic suggests B12 or folate deficiency.
- Fractional excretion of sodium
- A fractional excretion of sodium below one percent favors a prerenal cause of acute kidney injury, reflecting appropriate sodium retention by the kidney.
- Distributive shock features
- Distributive shock from sepsis, anaphylaxis, or neurogenic causes shows low systemic vascular resistance with warm extremities and bounding pulses in early stages.
- Most common typical pneumonia pathogen
- Streptococcus pneumoniae is the most frequent typical cause of community-acquired pneumonia; atypical causes include Mycoplasma, Chlamydophila, and Legionella species.
- Hypertension first-line drug classes
- First-line antihypertensives include thiazide diuretics, ACE inhibitors or ARBs, and calcium channel blockers; ACE inhibitors are avoided in pregnancy and bilateral renal artery stenosis.
- Sensitivity and specificity formulas
- Sensitivity equals true positives divided by true positives plus false negatives. Specificity equals true negatives divided by true negatives plus false positives.
- Predictive value and prevalence
- Positive predictive value increases as disease prevalence rises, while negative predictive value decreases as prevalence rises, even when sensitivity and specificity are unchanged.
- Number needed to treat
- Number needed to treat is the reciprocal of the absolute risk reduction; number needed to harm is the reciprocal of the absolute risk increase.
- Relative risk versus odds ratio
- Relative risk derives from cohort studies; the odds ratio approximates relative risk only when the outcome is rare, generally under ten percent.
- Confidence interval interpretation
- A 95 percent confidence interval excluding 1.0 for a ratio measure, or excluding 0 for a difference, indicates statistical significance at alpha equal to 0.05.
- Clinical trial phases
- Phase I assesses safety and dosing, Phase II assesses efficacy, Phase III compares against standard treatment, and Phase IV is post-marketing surveillance.
- Screening test requirements
- Screening tests require high sensitivity and a detectable preclinical phase with effective treatment; any positive screen is followed by a confirmatory test.
- Drug half-life and steady state
- Steady-state plasma concentration is reached after approximately four to five half-lives of consistent dosing; bioavailability is the fraction of dose reaching systemic circulation.
- Henderson-Hasselbalch relationship
- Plasma pH equals 6.1 plus the log of bicarbonate divided by 0.03 times carbon dioxide tension, linking respiratory and metabolic acid-base components.
- Cellular energy from fatty acids
- Beta-oxidation cleaves two-carbon units to acetyl-CoA for the citric acid cycle; ketone bodies form when hepatic acetyl-CoA exceeds cycle capacity.
- Acute coronary syndrome management
- ST-elevation myocardial infarction requires emergent reperfusion, either primary percutaneous coronary intervention or fibrinolysis when intervention is unavailable within recommended time limits.
- Diabetic ketoacidosis findings
- Diabetic ketoacidosis presents with hyperglycemia, anion-gap metabolic acidosis, and ketonemia; treatment uses isotonic fluids, insulin infusion, and potassium replacement.
- Cirrhosis complications
- Cirrhosis causes portal hypertension with ascites, esophageal varices, and hepatic encephalopathy; ascites is managed with sodium restriction, spironolactone, and furosemide.
- Cohort study design
- A cohort study follows exposed and unexposed groups forward in time to measure incidence and calculate relative risk and attributable risk.
- Case-control study design
- A case-control study identifies affected and unaffected individuals and looks backward at prior exposures, efficiently estimating odds ratios for rare diseases.
- Lead-time bias in screening
- Lead-time bias occurs when earlier detection appears to prolong survival by advancing diagnosis without changing the actual time of death.